Biofil Chemicals and Pharmaceuticals Limited (BOM:524396)
India · Delayed Price · Currency is INR 31.53
-1.11 (-3.40%)
At close: Aug 17, 2026
BOM:524396 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 33.26 | 2.55 | 22.84 | 0.38 | 1.45 |
Cash & Short-Term Investments | 33.26 | 33.26 | 2.55 | 22.84 | 0.38 | 1.45 |
Cash Growth | 1202.94% | 1202.94% | -88.82% | 5973.14% | -74.05% | -67.11% |
Accounts Receivable | - | 275.86 | 383.15 | 330.29 | 205.03 | 71.74 |
Other Receivables | - | - | - | - | - | 2.05 |
Receivables | - | 275.86 | 383.15 | 330.29 | 205.03 | 73.79 |
Inventory | - | 44.26 | 36.9 | 28.49 | 14.81 | 15.41 |
Prepaid Expenses | - | 0.09 | 0.09 | 0.09 | 0.96 | 2.48 |
Other Current Assets | - | 5.15 | 2.85 | 2.37 | 2.37 | - |
Total Current Assets | - | 358.63 | 425.54 | 384.08 | 223.54 | 93.13 |
Property, Plant & Equipment | - | 69.35 | 83.45 | 86.24 | 90.01 | 94.19 |
Other Long-Term Assets | - | 0.51 | 0.62 | 0.51 | 0.51 | -0 |
Total Assets | - | 428.48 | 509.6 | 470.83 | 314.06 | 187.32 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 170.6 | 309.88 | 275.55 | 126.5 | 5.96 |
Accrued Expenses | - | 0.37 | 0.32 | 0.31 | 0.37 | 0.66 |
Current Portion of Long-Term Debt | - | 30.2 | 4.71 | 4.39 | 5.22 | 4.65 |
Current Income Taxes Payable | - | 4.07 | 2.1 | 2.4 | 2.3 | 2.71 |
Other Current Liabilities | - | 1.65 | 1.47 | 2.59 | 2.86 | 0.97 |
Total Current Liabilities | - | 206.89 | 318.48 | 285.25 | 137.26 | 14.95 |
Long-Term Deferred Tax Liabilities | - | 5.95 | 3.31 | 3.55 | 3.79 | 4 |
Other Long-Term Liabilities | - | - | 0 | - | - | - |
Total Liabilities | - | 212.84 | 321.79 | 288.8 | 141.04 | 18.95 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 162.74 | 162.74 | 162.74 | 162.74 | 162.74 |
Additional Paid-In Capital | - | - | 83.33 | 83.33 | 83.33 | 83.33 |
Retained Earnings | - | - | -113.66 | -119.44 | -128.46 | -133.1 |
Comprehensive Income & Other | - | 52.91 | 55.4 | 55.4 | 55.4 | 55.4 |
Shareholders' Equity | 215.64 | 215.64 | 187.81 | 182.03 | 173.02 | 168.38 |
Total Liabilities & Equity | - | 428.48 | 509.6 | 470.83 | 314.06 | 187.32 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 30.2 | 30.2 | 4.71 | 4.39 | 5.22 | 4.65 |
Net Cash (Debt) | 3.06 | 3.06 | -2.16 | 18.45 | -4.85 | -3.2 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.19 | 0.19 | -0.13 | 1.13 | -0.30 | -0.20 |
Filing Date Shares Outstanding | 15.59 | 16.32 | 16.27 | 16.27 | 16.27 | 16.27 |
Total Common Shares Outstanding | 15.59 | 16.32 | 16.27 | 16.27 | 16.27 | 16.27 |
Working Capital | - | 151.73 | 107.06 | 98.83 | 86.29 | 78.18 |
Book Value Per Share | 13.21 | 13.21 | 11.54 | 11.19 | 10.63 | 10.35 |
Tangible Book Value | 215.64 | 215.64 | 187.81 | 182.03 | 173.02 | 168.38 |
Tangible Book Value Per Share | 13.21 | 13.21 | 11.54 | 11.19 | 10.63 | 10.35 |
Land | - | - | 44.96 | 44.96 | 44.96 | 44.96 |
Buildings | - | - | 30.12 | 30.12 | 29.9 | 29.8 |
Machinery | - | - | 42.43 | 41.43 | 41.42 | 41.41 |